Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes

Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes

Abstract The definitive treatment for end-stage renal disease is kidney transplantation, which remains limited by organ availability and post-transplant complications. Alternatively, an implantable bioartificial kidney could address both problems while enhancing the quality and length of patient lif...

Full description

Bibliographic Details
Main Authors: Eun Jung Kim, Caressa Chen, Rebecca Gologorsky, Ana Santandreu, Alonso Torres, Nathan Wright, Mark S. Goodin, Jarrett Moyer, Benjamin W. Chui, Charles Blaha, Paul Brakeman, Shant Vartanian, Qizhi Tang, H. David Humes, William H. Fissell, Shuvo Roy
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39888-2

Internet

https://doi.org/10.1038/s41467-023-39888-2

Similar Items